Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in Amendment No. 3 to the Registration Statement on Form S-1 and related Prospectus of Onconova Therapeutics, Inc. for the registration of up to $57,500,000 of securities, and to the incorporation by reference therein of our report dated March 16, 2018, with respect to the consolidated financial statements of Onconova Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP |
|
|
Philadelphia, Pennsylvania |
|
April 26, 2018 |
|
